Correction to: The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells

The original article can be found online.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacological reports 2021-02, Vol.73 (1), p.316-316
Hauptverfasser: Bou-Gharios, Jolie, Assi, Sahar, Bahmad, Hisham F., Kharroubi, Hussein, Araji, Tarek, Chalhoub, Reda M., Ballout, Farah, Harati, Hayat, Fares, Youssef, Abou-Kheir, Wassim
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 316
container_issue 1
container_start_page 316
container_title Pharmacological reports
container_volume 73
creator Bou-Gharios, Jolie
Assi, Sahar
Bahmad, Hisham F.
Kharroubi, Hussein
Araji, Tarek
Chalhoub, Reda M.
Ballout, Farah
Harati, Hayat
Fares, Youssef
Abou-Kheir, Wassim
description The original article can be found online.
doi_str_mv 10.1007/s43440-020-00194-z
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2466033782</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2466033782</sourcerecordid><originalsourceid>FETCH-LOGICAL-c187z-c201b6321d1ed16499e5b442734d18843eddb26cb2164890a041877940803b353</originalsourceid><addsrcrecordid>eNp9Uctu2zAQJIoGjfP4gR4CHnthypckqrfASJMCAXJJzgQlrm06lOjyUaD-hnx06TrpsYfFArszg50dhD4zes0o7b4mKaSkhPJalPWS7D-gBed9T5pWyY9owTohCWOSnqKzlLaUSsZF8wmdCsGbnkq1QK_LECOM2YUZ5_ANP20A70KGOTvjcUmAwwpnZ2HtS3IDNgmbGRu7Lb_MnHE01gWSNxDNDkp2I84RTJ4qH69CxGvvwuBNymEyeCo-uzqdAI9mHiHilGEi3r3UAXifLtDJyvgEl2_9HD1_v31a3pOHx7sfy5sHMjLV7cnIKRtawZllYFkr-x6aQUpe3VqmlBRg7cDbceB1qXpqqm_Vdb2kiopBNOIcfTnq7mL4WSBlPbl0uMDMEErSXLYtFaJTvEL5ETrGkFKEld5FN5n4WzOqDynoYwq6pqD_pqD3lXT1pl-GCew_yvvbK0AcAamu5jVEvQ0lztXz_2T_AEw_lL0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2466033782</pqid></control><display><type>article</type><title>Correction to: The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells</title><source>Springer Nature - Complete Springer Journals</source><creator>Bou-Gharios, Jolie ; Assi, Sahar ; Bahmad, Hisham F. ; Kharroubi, Hussein ; Araji, Tarek ; Chalhoub, Reda M. ; Ballout, Farah ; Harati, Hayat ; Fares, Youssef ; Abou-Kheir, Wassim</creator><creatorcontrib>Bou-Gharios, Jolie ; Assi, Sahar ; Bahmad, Hisham F. ; Kharroubi, Hussein ; Araji, Tarek ; Chalhoub, Reda M. ; Ballout, Farah ; Harati, Hayat ; Fares, Youssef ; Abou-Kheir, Wassim</creatorcontrib><description>The original article can be found online.</description><identifier>ISSN: 1734-1140</identifier><identifier>EISSN: 2299-5684</identifier><identifier>DOI: 10.1007/s43440-020-00194-z</identifier><identifier>PMID: 33259048</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Correction ; Drug Safety and Pharmacovigilance ; Medicine ; Pharmacotherapy ; Pharmacy</subject><ispartof>Pharmacological reports, 2021-02, Vol.73 (1), p.316-316</ispartof><rights>Maj Institute of Pharmacology Polish Academy of Sciences 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0001-9719-9324</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s43440-020-00194-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s43440-020-00194-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33259048$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bou-Gharios, Jolie</creatorcontrib><creatorcontrib>Assi, Sahar</creatorcontrib><creatorcontrib>Bahmad, Hisham F.</creatorcontrib><creatorcontrib>Kharroubi, Hussein</creatorcontrib><creatorcontrib>Araji, Tarek</creatorcontrib><creatorcontrib>Chalhoub, Reda M.</creatorcontrib><creatorcontrib>Ballout, Farah</creatorcontrib><creatorcontrib>Harati, Hayat</creatorcontrib><creatorcontrib>Fares, Youssef</creatorcontrib><creatorcontrib>Abou-Kheir, Wassim</creatorcontrib><title>Correction to: The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells</title><title>Pharmacological reports</title><addtitle>Pharmacol. Rep</addtitle><addtitle>Pharmacol Rep</addtitle><description>The original article can be found online.</description><subject>Correction</subject><subject>Drug Safety and Pharmacovigilance</subject><subject>Medicine</subject><subject>Pharmacotherapy</subject><subject>Pharmacy</subject><issn>1734-1140</issn><issn>2299-5684</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9Uctu2zAQJIoGjfP4gR4CHnthypckqrfASJMCAXJJzgQlrm06lOjyUaD-hnx06TrpsYfFArszg50dhD4zes0o7b4mKaSkhPJalPWS7D-gBed9T5pWyY9owTohCWOSnqKzlLaUSsZF8wmdCsGbnkq1QK_LECOM2YUZ5_ANP20A70KGOTvjcUmAwwpnZ2HtS3IDNgmbGRu7Lb_MnHE01gWSNxDNDkp2I84RTJ4qH69CxGvvwuBNymEyeCo-uzqdAI9mHiHilGEi3r3UAXifLtDJyvgEl2_9HD1_v31a3pOHx7sfy5sHMjLV7cnIKRtawZllYFkr-x6aQUpe3VqmlBRg7cDbceB1qXpqqm_Vdb2kiopBNOIcfTnq7mL4WSBlPbl0uMDMEErSXLYtFaJTvEL5ETrGkFKEld5FN5n4WzOqDynoYwq6pqD_pqD3lXT1pl-GCew_yvvbK0AcAamu5jVEvQ0lztXz_2T_AEw_lL0</recordid><startdate>202102</startdate><enddate>202102</enddate><creator>Bou-Gharios, Jolie</creator><creator>Assi, Sahar</creator><creator>Bahmad, Hisham F.</creator><creator>Kharroubi, Hussein</creator><creator>Araji, Tarek</creator><creator>Chalhoub, Reda M.</creator><creator>Ballout, Farah</creator><creator>Harati, Hayat</creator><creator>Fares, Youssef</creator><creator>Abou-Kheir, Wassim</creator><general>Springer International Publishing</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9719-9324</orcidid></search><sort><creationdate>202102</creationdate><title>Correction to: The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells</title><author>Bou-Gharios, Jolie ; Assi, Sahar ; Bahmad, Hisham F. ; Kharroubi, Hussein ; Araji, Tarek ; Chalhoub, Reda M. ; Ballout, Farah ; Harati, Hayat ; Fares, Youssef ; Abou-Kheir, Wassim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c187z-c201b6321d1ed16499e5b442734d18843eddb26cb2164890a041877940803b353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Correction</topic><topic>Drug Safety and Pharmacovigilance</topic><topic>Medicine</topic><topic>Pharmacotherapy</topic><topic>Pharmacy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bou-Gharios, Jolie</creatorcontrib><creatorcontrib>Assi, Sahar</creatorcontrib><creatorcontrib>Bahmad, Hisham F.</creatorcontrib><creatorcontrib>Kharroubi, Hussein</creatorcontrib><creatorcontrib>Araji, Tarek</creatorcontrib><creatorcontrib>Chalhoub, Reda M.</creatorcontrib><creatorcontrib>Ballout, Farah</creatorcontrib><creatorcontrib>Harati, Hayat</creatorcontrib><creatorcontrib>Fares, Youssef</creatorcontrib><creatorcontrib>Abou-Kheir, Wassim</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacological reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bou-Gharios, Jolie</au><au>Assi, Sahar</au><au>Bahmad, Hisham F.</au><au>Kharroubi, Hussein</au><au>Araji, Tarek</au><au>Chalhoub, Reda M.</au><au>Ballout, Farah</au><au>Harati, Hayat</au><au>Fares, Youssef</au><au>Abou-Kheir, Wassim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correction to: The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells</atitle><jtitle>Pharmacological reports</jtitle><stitle>Pharmacol. Rep</stitle><addtitle>Pharmacol Rep</addtitle><date>2021-02</date><risdate>2021</risdate><volume>73</volume><issue>1</issue><spage>316</spage><epage>316</epage><pages>316-316</pages><issn>1734-1140</issn><eissn>2299-5684</eissn><abstract>The original article can be found online.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>33259048</pmid><doi>10.1007/s43440-020-00194-z</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-9719-9324</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1734-1140
ispartof Pharmacological reports, 2021-02, Vol.73 (1), p.316-316
issn 1734-1140
2299-5684
language eng
recordid cdi_proquest_miscellaneous_2466033782
source Springer Nature - Complete Springer Journals
subjects Correction
Drug Safety and Pharmacovigilance
Medicine
Pharmacotherapy
Pharmacy
title Correction to: The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T18%3A03%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correction%20to:%20The%20potential%20use%20of%20tideglusib%20as%20an%20adjuvant%20radio-therapeutic%20treatment%20for%20glioblastoma%20multiforme%20cancer%20stem-like%20cells&rft.jtitle=Pharmacological%20reports&rft.au=Bou-Gharios,%20Jolie&rft.date=2021-02&rft.volume=73&rft.issue=1&rft.spage=316&rft.epage=316&rft.pages=316-316&rft.issn=1734-1140&rft.eissn=2299-5684&rft_id=info:doi/10.1007/s43440-020-00194-z&rft_dat=%3Cproquest_cross%3E2466033782%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2466033782&rft_id=info:pmid/33259048&rfr_iscdi=true